Partial mTORC1 inhibition reserves the limited AAs derived from macropinocytosis, favors the growth of macropinocytosis-dependent cancer cells, and enhances the growth of KRAS-induced pancreatic cancer58. The gene discussed is KRAS; the disease is cancer.